financetom
Business
financetom
/
Business
/
Wells Fargo sues JPMorgan over troubled $481 million real estate loan
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Wells Fargo sues JPMorgan over troubled $481 million real estate loan
Mar 10, 2025 11:03 AM

NEW YORK, March 10 (Reuters) - Wells Fargo ( WFC ) sued

JPMorgan Chase ( JPM ) on Monday to recover losses for investors

in a $481 million commercial real estate loan that was allegedly

based on a fraudulently inflated financial metric.

The lawsuit pits the fourth-largest U.S. bank against the

largest, with Wells Fargo ( WFC ) accusing JPMorgan ( JPM ) of turning a blind

eye during due diligence in pursuit of millions of dollars in

fees.

JPMorgan ( JPM ) made the loan to finance the 2019 purchase by the

Chetrit Group, a private Manhattan real estate development firm,

of 43 multifamily properties with 8,671 apartments in 10 U.S.

states.

Wells Fargo ( WFC ), in its role as the investors' trustee, said

JPMorgan ( JPM ) and Chetrit learned before the $522 million purchase

closed that the seller overstated the properties' historical net

operating income, a key commercial real estate metric, by 25%.

But according to the complaint in Manhattan federal court,

JPMorgan ( JPM ) went ahead with the loan, knowing it would eventually

be sold in pieces to unwitting investors.

The borrower defaulted in 2022 and still owes more than $285

million, while investors have lost tens of millions of dollars,

Wells Fargo ( WFC ) said.

"JPM had an obligation to engage in due inquiry to determine

the scope of the fraudulent reporting" after learning about the

inflated metric, Wells Fargo ( WFC ) said.

"Instead, JPM plowed ahead as if nothing unusual had

happened," Wells Fargo ( WFC ) added, "without even bothering to correct

known errors in the numbers."

The defendants also include Meyer Chetrit, a Chetrit Group

principal who provided a loan guaranty.

JPMorgan ( JPM ) and the Chetrit Group had no immediate comment.

Wells Fargo ( WFC ) wants New York-based JPMorgan ( JPM ) to repurchase the

loan, less amounts the trust received from sales of underlying

properties, or else pay damages for breach of contract.

Lawyers for San Francisco-based Wells Fargo ( WFC ) did not

immediately respond to requests for additional comment.

The case is Wells Fargo Bank NA as trustee v JPMorgan Chase

Bank NA et al, U.S. District Court, Southern District of New

York, No. 25-01943.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
McCormick & Co Insider Sold Shares Worth $3,746,361, According to a Recent SEC Filing
McCormick & Co Insider Sold Shares Worth $3,746,361, According to a Recent SEC Filing
Nov 13, 2025
04:47 PM EST, 11/13/2025 (MT Newswires) -- Brendan M Foley, Chairman, President & CEO, on November 12, 2025, sold 57,144 shares in McCormick ( MKC ) & Co (MKC) for $3,746,361. Following the Form 4 filing with the SEC, Foley has control over a total of 109,797 common shares of the company, with 109,797 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/63754/000006375425000099/xslF345X05/form4.xml...
Globant Q3 Adjusted Earnings Fall, Revenue Rises; Issues Q4 Outlook
Globant Q3 Adjusted Earnings Fall, Revenue Rises; Issues Q4 Outlook
Nov 13, 2025
04:48 PM EST, 11/13/2025 (MT Newswires) -- Globant ( GLOB ) reported Q3 adjusted earnings late Thursday of $1.53 per diluted share, down from $1.63 a year earlier. Analysts polled by FactSet expected $1.54. Revenue for the quarter ended Sept. 30 was $617.1 million, up from $614.7 million a year earlier. Analysts surveyed by FactSet expected $615.2 million. The company...
TriSalus Life Sciences Q3 Loss Widens, Revenue Rises
TriSalus Life Sciences Q3 Loss Widens, Revenue Rises
Nov 13, 2025
04:44 PM EST, 11/13/2025 (MT Newswires) -- TriSalus Life Sciences ( TLSI ) reported a Q3 loss of $0.96 per diluted share, widening from a loss of $0.12 a year earlier. Analysts polled by FactSet expected a loss of $0.15. Revenue for the three months ended Sept. 30 was $11.6 million, up from $7.3 million a year earlier. Analysts surveyed...
Starz Q3 Loss Widens, Revenue Falls
Starz Q3 Loss Widens, Revenue Falls
Nov 13, 2025
04:44 PM EST, 11/13/2025 (MT Newswires) -- Starz (STRZ) reported a Q3 loss late Thursday of $3.15 per diluted share, wider than a loss of $1.83 a year earlier. Four analysts polled by FactSet expected a loss of $0.93. Revenue for the quarter ended Sept. 30 was $320.9 million, down from $346.9 million a year earlier. Analysts surveyed by FactSet...
Copyright 2023-2026 - www.financetom.com All Rights Reserved